Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 39 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Myocardial Mechanisms in HFpEF

    Rochester, MN

  2. Mayo Clinic Cardiovascular Disease Biobank

    Rochester, MN

  3. Ex-CMR In HFpEF

    Rochester, MN

  4. A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

    Rochester, MN

  5. A Study to Evaluate the Burden of Treatment and Illness in Advanced Heart Failure Patients

    Rochester, MN

  6. Heart Failure (HF) Clinic Biobank

    Rochester, MN

  7. Care Partners And Patients Navigating Year 1 Of Dyadic Self-Management Post-LVAD

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. Hospital Diuretic Therapy and Associated Risk of Heart Failure in Treating Fluid Volume Overload

    Rochester, MN

  9. His Bundle Pacing in Bradycardia and Heart Failure

    Rochester, MN

  10. A Study of 68GA-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure

    Rochester, MN

.

Mayo Clinic Footer